Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy

被引:0
|
作者
Taylor, Edward [1 ,2 ]
Lukovic, Jelena [1 ,2 ]
Velec, Michael [1 ,2 ]
Shessel, Andrea [1 ]
Stanescu, Teodor [1 ,2 ]
Dawson, Laura [1 ,2 ]
Letourneau, Daniel [1 ,2 ]
Lindsay, Patricia [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
关键词
Image guided radiotherapy; magnetic resonance imaging; liver cancer; stereotactic body radiotherapy; RADIATION-THERAPY SMART; MALIGNANCIES; ABDOMEN; PELVIS; THORAX; IMPACT;
D O I
10.1080/0284186X.2020.1840625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Liver cancers are challenging to treat using image-guided radiotherapy (IGRT) due to motion and deformation of target volumes and organs at risk (OARs), as well as difficulties in visualising liver tumours using cone-beam computed tomography (CBCT) based IGRT. Liver cancer patients may thus benefit from magnetic resonance (MR)-guided daily adaptive re-planning. We evaluated the dosimetric impact of a daily plan adaptation strategy based on daily MR imaging versus CBCT-based IGRT. Methods Ten patients were studied who were treated with CBCT-guided five-fraction stereotactic body radiotherapy (SBRT) and underwent MR imaging before each fraction. Simulated reference plans were created on computer tomography (CT) images and adapted plans were created on the daily MR images. Two plan adaptation strategies were retrospectively simulated: (1) translational couch shifts to match liver, mimicking standard CBCT guidance and (2) daily plan adaptation based on reference plan clinical goals and daily target and OAR contours. Dose statistics were calculated for both strategies and compared. Results Couch shifts resulted in an average reduction in GTV D99% relative to reference plan values of 5.2 Gy (-12.5% of reference values). Daily plan adaptation reduced this to 0.8 Gy (-2.0%). For six patients who were OAR dose-limited on reference plans, couch shifts resulted in OAR dose violations in 28 out of 28 simulated fractions, respectively; no violations occurred using daily plan adaptation. No OAR dose violations occurred using either strategy for the four cases not OAR dose-limited at reference planning. Conclusions MR-guided daily plan adaptation ensured OAR dose constraints were met at all simulated treatment fractions while CBCT-based IGRT resulted in a systematic over-dosing of OARs in patients whose doses were limited by OAR dose at the time of reference planning.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 50 条
  • [31] Magnetic Resonance-guided stereotactic Radiotherapy for Patients with malignant Liver Neoplasms: First clinical Experience and Patient-Reported Outcome
    Weykamp, F.
    Klueter, S.
    Hoegen, P.
    Seidensaal, K.
    Koenig, L.
    Renkamp, K.
    Rippke, C.
    Regnery, S.
    Koerber, S.
    Buchele, C.
    Debus, J.
    Liermann, J.
    Horner-Rieber, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S65 - S65
  • [32] The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
    Mutic, Sasa
    Dempsey, James F.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 196 - 199
  • [33] Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System
    Feldman, Aharon M.
    Modh, Ankit
    Glide-Hurst, Carri
    Chetty, Indrin T.
    Movsas, Benjamin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [34] Reducing the Toxicity of Radiotherapy for Pancreatic Cancer With Magnetic Resonance-guided Radiotherapy
    Tchelebi, Leila T.
    Zaorsky, Nicholas G.
    Rosenberg, Jennifer C.
    Sharma, Navesh K.
    Tuanquin, Leonard C.
    Mackley, Heath B.
    Ellis, Rodney J.
    TOXICOLOGICAL SCIENCES, 2020, 175 (01) : 19 - 23
  • [35] Reduction in Normal Tissue Complication Probability by Stereotactic Magnetic Resonance-Guided Ablative Radiotherapy for Adrenal Lesions
    Chen, H.
    de Koste, J. R. van Sornsen
    Bohoudi, O.
    Bruynzeel, A.
    Slotman, B. J.
    Lagerwaard, F.
    Palacios, M.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S65 - S66
  • [36] Delta radiomics to track radiation response in lung tumors receiving stereotactic magnetic resonance-guided radiotherapy
    Zha, Yining
    Ye, Zezhong
    Zapaishchykova, Anna
    He, John
    Hsu, Shu-Hui
    Leeman, Jonathan E.
    Fitzgerald, Kelly J.
    Kozono, David E.
    Mak, Raymond H.
    Aerts, Hugo J. W. L.
    Kann, Benjamin H.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 31
  • [37] Biologically Equivalent Dose Comparison Between Magnetic Resonance-Guided Adaptive and Computed Tomography-Guided Internal Target Volume-Based Stereotactic Body Radiotherapy for Liver Tumors
    Yoda, Kiyoshi
    Sato, Aya
    Miyake, Yuta
    Arato, Takeru
    Starbuck, William
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [38] Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
    Portelance, Lorraine
    Corradini, Stefanie
    Erickson, Beth
    Lalondrelle, Susan
    Padgett, Kyle
    van der Leij, Femke
    van Lier, Astrid
    Jurgenliemk-Schulz, Ina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Magnetic resonance-guided radiotherapy (MRgRT) for patients with lung cancer
    Crockett, Cathryn
    Chuter, Robert
    Cobben, David
    Dubec, Michael
    Green, Olga
    Hackett, Sara
    McDonald, Fiona
    Robinson, Clifford
    Samson, Pamela
    Shiarli, Anna-Maria
    Straza, Michael
    Verhoeff, Joost
    Vlacich, Gregory
    Werner-Wasik, Maria
    Faivre-Finn, Corinne
    LUNG CANCER, 2021, 156 : S62 - S62
  • [40] Magnetic resonance-guided stereotactic biopsies: Results in 100 consecutive cases
    Fontaine, D
    Dormont, D
    Hasboun, D
    Clemenceau, S
    Valery, C
    Oppenheim, C
    Sahel, M
    Marsault, C
    Philippon, J
    Cornu, P
    ACTA NEUROCHIRURGICA, 2000, 142 (03) : 249 - 256